Massmutual Trust CO Fsb Supernus Pharmaceuticals, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.28 Billion
- Q2 2024
A detailed history of Massmutual Trust CO Fsb transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 101 shares of SUPN stock, worth $3,055. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101
Previous 320
68.44%
Holding current value
$3,055
Previous $10,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SUPN
# of Institutions
257Shares Held
57.3MCall Options Held
84.1KPut Options Held
61.2K-
Black Rock Inc. New York, NY10.4MShares$313 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$188 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY3.57MShares$108 Million1.66% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$80.7 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$77.3 Million0.02% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.62B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...